| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
1.04M |
$3.43M |
$3.30 |
Apr 9, 2025 |
Direct |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
250K |
$825K |
$3.30 |
Apr 9, 2025 |
By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
250K |
$825K |
$3.30 |
Apr 9, 2025 |
By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
95K |
$314K |
$3.30 |
Apr 9, 2025 |
By Fried-Travis Revocable Trust U/A Dated 06/02/1999 |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Common Stock |
12.7K |
$42.1K |
$3.30 |
Apr 9, 2025 |
Indirect |
| ChromaDex Corp. |
Chief Executive Officer, Director |
Performance Stock Unit |
1.52M |
|
|
Feb 25, 2025 |
Direct |
| ChromaDex Corp. |
Chief Executive Officer, Director |
Employee Stock Options (right to buy) |
492K |
|
|
Feb 12, 2025 |
Direct |
| Niagen Bioscience, Inc. |
Chief Executive Officer, Director |
Stock Options (right to buy) |
0 |
|
|
Apr 9, 2025 |
Direct |